Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Most off-label drug prescriptions in Saudi Arabia are for adults with depression and diabetes.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Testosterone may influence COVID-19 severity and outcomes.

Several companies launched new hair care ingredients in 2011 to improve conditioning, color retention, combability, and heat protection.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.